Home » Topics » BioWorld Science

BioWorld Science
RSS

Chengdu Euthare Therapeutics synthesizes CDK4 and CDK6 inhibitors

Dec. 18, 2018

Abbisko Therapeutics divulges new CSF-1R inhibitors

Dec. 18, 2018

Cancer Research Technology patents BCL-6 inhibitors

Dec. 18, 2018

Reduced RNA editing links different forms of autism

Dec. 18, 2018

CB-103 demonstrates synergistic activity with fulvestrant in ER-positive breast cancer

Dec. 18, 2018

Preclinical data presented for CYT-0851

Dec. 18, 2018

Modulation of brain dopamine release by Takeda's GPCR139 agonist TAK-041

Dec. 18, 2018

Recombinant measles virus expressing NIS demonstrates antitumor activity in metastatic breast cancer

Dec. 18, 2018

HER mutations can cause ER resistance

Dec. 18, 2018

Resolvin receptor analogues limit inflammation

Dec. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...